ADVBAdvanced Biomed Inc.
Health Care
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest revised up 66.7% for FY 2025
This is the 3rd largest revision in ADVB's history.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2025
Major restatement-$1.1M▲ 66.7%
was-$3.3M
Revised up in a 10-K.
No amendment filed
As reported · Oct 9, 202510-K · Oct 14, 2026us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestVerify against SEC filingsShow
As reported-$3.3M
Accepted 2025-10-090001213900-25-097465
Restated-$1.1M
Accepted 2026-10-140001213900-26-109029
PretaxIncome · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time ADVB — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.